Henry Schein Stock Appears To Be Fairly Valued
- By GF Value
The stock of Henry Schein (NAS:HSIC, 30-year Financials) appears to be fairly valued, according to GuruFocus Value calculation. GuruFocus Value is GuruFocus' estimate of the fair value at which the stock should be traded. It is calculated based on the historical multiples that the stock has traded at, the past business growth and analyst estimates of future business performance. If the price of a stock is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher. At its current price of $78.91 per share and the market cap of $11.2 billion, Henry Schein stock is estimated to be fairly valued. GF Value for Henry Schein is shown in the chart below.
Because Henry Schein is fairly valued, the long-term return of its stock is likely to be close to the rate of its business growth, which averaged 7.9% over the past three years and is estimated to grow 4.38% annually over the next three to five years.
Link: These companies may deliever higher future returns at reduced risk.
Since investing in companies with low financial strength could result in permanent capital loss, investors must carefully review a company's financial strength before deciding whether to buy shares. Looking at the cash-to-debt ratio and interest coverage can give a good initial perspective on the company's financial strength. Henry Schein has a cash-to-debt ratio of 0.42, which ranks worse than 70% of the companies in Medical Distribution industry. Based on this, GuruFocus ranks Henry Schein's financial strength as 6 out of 10, suggesting fair balance sheet. This is the debt and cash of Henry Schein over the past years:
Investing in profitable companies carries less risk, especially in companies that have demonstrated consistent profitability over the long term. Typically, a company with high profit margins offers better performance potential than a company with low profit margins. Henry Schein has been profitable 10 years over the past 10 years. During the past 12 months, the company had revenues of $10.1 billion and earnings of $2.82 a share. Its operating margin of 5.61% in the middle range of the companies in Medical Distribution industry. Overall, GuruFocus ranks Henry Schein's profitability as fair. This is the revenue and net income of Henry Schein over the past years:
Growth is probably the most important factor in the valuation of a company. GuruFocus research has found that growth is closely correlated with the long term stock performance of a company. A faster growing company creates more value for shareholders, especially if the growth is profitable. The 3-year average annual revenue growth of Henry Schein is 7.9%, which ranks in the middle range of the companies in Medical Distribution industry. The 3-year average EBITDA growth rate is -0.5%, which ranks worse than 78% of the companies in Medical Distribution industry.
Another way to look at the profitability of a company is to compare its return on invested capital and the weighted cost of capital. Return on invested capital (ROIC) measures how well a company generates cash flow relative to the capital it has invested in its business. The weighted average cost of capital (WACC) is the rate that a company is expected to pay on average to all its security holders to finance its assets. We want to have the return on invested capital higher than the weighted cost of capital. For the past 12 months, Henry Schein's return on invested capital is 8.66, and its cost of capital is 6.48. The historical ROIC vs WACC comparison of Henry Schein is shown below:
To conclude, the stock of Henry Schein (NAS:HSIC, 30-year Financials) shows every sign of being fairly valued. The company's financial condition is fair and its profitability is fair. Its growth ranks worse than 78% of the companies in Medical Distribution industry. To learn more about Henry Schein stock, you can check out its 30-year Financials here.
To find out the high quality companies that may deliever above average returns, please check out GuruFocus High Quality Low Capex Screener.
This article first appeared on GuruFocus.
